CD8A and neoplasm: In this study, i.n. vaccination with Shiga toxin B subunit fused to the HPV16-E7 tumor/viral peptide (STxB-E7) gave rise to E739−47-specific CD8+ T cells in mucosa-draining lymph nodes.